Navigation Links
2007 hurricane forecasts took blow from winds and Saharan dry, dusty air
Date:8/18/2008

which the dry air and associated dust spread across the tropical North Atlantic, as seen by instruments aboard NASA satellites such as the Moderate Resolution Imaging Spectroradiometer. They created a "wind-stretch index," based on the east-west difference in wind speed over the tropical Atlantic. The index is connected to relative humidity over the tropical western Atlantic, and is a perfect measure of how far west dry air and dust from Africa extends over the North Atlantic.

The team found that instances of Saharan dry air and dust extending far west over the Caribbean were in sync with conditions that contributed to fewer hurricanes in both 2007 and 2006, including lower sea surface temperatures. They also found that the far-reaching western extent of dust in 2006 and 2007 was associated with less-than-normal humidity over the western North Atlantic.

"This index hasn't been looked at before," said Lau. "We introduce a way to relate wind stretch to dry air and dust, which correlate very well with humidity in the western tropical Atlantic."

The link between dust and humidity, the researchers say, could aid future forecasts. As dust outbreaks occur most often in early summer prior to peak hurricane season, researchers could use a measure of humidity in the western tropical Atlantic to gauge the extent of dust transport, possibly providing an additional parameter to estimate the following month's hurricane activity.

"The index we proposed may provide practical implications for the prediction of Atlantic hurricane activities," says Donglian Sun of George Mason University in Fairfax Va., and lead author of the study. "Further studies are needed to discern the general prediction capability of our results."

If the index is on target, the team believes it could also describe dust's role in past hurricane seasons. Records of historical wind data from ground stations could be applied to the index to infer the westward extent of
'/>"/>

Contact: Lynn Chandler
lynn.chandler-1@nasa.gov
301-286-2806
NASA/Goddard Space Flight Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Climates remote control on hurricanes
2. Soil, conservation experts to reflect on Hurricane Katrina disaster
3. Air quality forecasts for China
4. Air quality forecasts see future in space
5. Research forecasts increased chances for stormy weather
6. UGA researchers discover mechanism that explains how cancer enzyme winds up on ends of chromosomes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009).... 26 BIO-key Internation...inger-based biometric identification software is s...the AABB TXPO conference being held at the New Orl...O-key will provide hands-on product demonstrations... in booth #424. Also, at 5 PM on Monday, October 2...
(Date:11/3/2009)...BER 4, 2009 -- The world,s greatest wines are the..., human input, and something called the "terroir" ..., and climate. , Experts will discuss terroir ... Wednesday, Nov. 4 in Pittsburgh. "Terroir: Wineg...o parts at the 2009 Annual Meetings of the America...
(Date:11/3/2009)... Obese women are as much as 28 percent less likel...cy, according to research that earned a Michigan S...e findings by Barbara Luke, a researcher in the MS...rics, Gynecology and Reproductive Biology, focused...roductive technology. , Luke,s findings, which a...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Great wines come from great soils 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 1Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 2Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 3China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 1China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
...for controlling a first key step in the creation o... the journal Nature tomorrow (Thursday 27 October ... early processes that take place once a sperm ente...ndamental process in sexually reproducing animals....ternal (mother,s) genome explains why eggs fail to...
...toxicological study on water-soluble buckyballs, r...cal and Environmental Nanotechnology (CBEN) find t...ly less toxic to begin with. Moreover, the researc...ndered nontoxic with minor chemical modifications....studies of water-soluble carbon nanotubes. The stu...
...ty of California, San Diego that appears in the Au...hat females of the species Uca crenulata may check...ows before finally deciding on a mate. , “As far a...ing nearly as many candidates as the California fi... the study while a doctoral student and a lecturer...
Other Biology News:Scientists unpick genetics of first 15 minutes of life 2Modifications render carbon nanotubes nontoxic 2Modifications render carbon nanotubes nontoxic 3Biologist Discovers What May Be World’s ‘Pickiest?Mates 2Biologist Discovers What May Be World’s ‘Pickiest?Mates 3
(Date:11/6/2009)...Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech..."Company") today announced updated results from a ...nts with sarcomas metastatic to the lung in a post...ue Oncology Society Meeting held in Miami Beach, F...ntation, entitled "A Phase II Study of Intravenous...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 P...h is set to take place on February 22-24, 2010 in ...y conference we will highlight key issues in formi...are their experiences. , ...enda for Arrowhead’s 2010 Personalized Medi...
(Date:11/5/2009)...URG, Md., Nov. 5 GenVec,...al results for the third quarter ended September 3...n ($0.04 per share) for the three months ended Sep...lion ($0.08 per share) in the comparable quarter o...09, GenVec,s net loss was $14.1 million ($0.15 per...
(Date:11/5/2009)...Y, N.J., Nov. 5 DSM Pharmaceutical...acturing alliance with Galenix, Saint Jean D,Illac...al scale manufacturing partner for Galenix commerc...nix will collaborate on business development oppor...logies, based on the strength of Galenix in drug p...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...IA, Calif., April 28 MannKind,Corporation (Nasdaq...commercializing treatments for diabetes and cancer...an Stanley Healthcare Conference on Wednesday,Apri...Biscayne, Florida., Interested parties can access...n the Investor Relations section of the Company,s ...
...KNOLLS, N.J., April 28 Emisphere,Technologies, In...08 it,received a letter from the NASDAQ Stock Mark...st 10 consecutive trading days, the Company,s,mark...inimum $50,000,000,requirement for continued inclu...Q Marketplace Rule 4450(b)(1)(A). Furthermore, NAS...
...ND, Calif., April 28 Sangamo,BioSciences, Inc. (N...opment,of novel zinc finger DNA-binding proteins (...tion, announced today the nomination of Thomas G.,... Wiggans most recently served as Chief Executive O...ompany, from 1994, and as Chairman,of the Board fr...
Other Biology Technology:Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4
GIBCO Streptomycin Sulfate from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Goat Anti-Adducin beta (C-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen
Biology Products: